IP Library › Assignment 074171/0534
Patent Assignment
Reel/Frame 074171/0534

Assignment of Assignor's Interest

Recorded: 2026-03-24 Pages: 10
Assignor
EOLAS THERAPEUTICS, INC.
Executed: 2026-01-07
Assignee
NIUVERA BIO, INC.
300 TECHNOLOGY SQUARE, 8TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02319
Covered Properties (3)
Substituted Prolines / Piperidines as Orexin Receptor Antagonists
Patent: 9,499,517 →
Application: 14/179,432 →
Publication: US 2014/0364432
Substituted Prolines / Piperidines as Orexin Receptor Antagonists
Patent: 9,440,982 →
Application: 14/460,289 →
Publication: US 2014/0364433
Substituted Prolines / Piperidines as Orexin Receptor Antagonists
Patent: 9,896,452 →
Application: 15/299,230 →
Publication: US 2017/0101410
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 11, 2015
From: KAMENECKA, THEODORE M.; HE, YUANJUN; JIANG, RONG; NGUYEN, WILLIAM
To: EOLAS THERAPEUTICS, INC.
Reel/Frame 034943/0400 →
Confirmatory License Dec 14, 2016
From: PAUL J. KENNY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040939/0835 →
Confirmatory License Dec 14, 2016
From: PAUL J. KENNY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040939/0837 →
Assignment of Assignor's Interest Jan 13, 2017
From: KAMENECKA, THEODORE M.; HE, YUANJUN; NGUYEN, WILLIAM; JIANG, RONG
To: EOLAS THERAPEUTICS, INC.
Reel/Frame 041366/0463 →
Assignment of Assignor's Interest Mar 24, 2026
From: JIANG, QIN; HERR, ROBERT JASON
To: CURIA GLOBAL, INC.
Reel/Frame 074171/0406 →
Assignment of Assignor's Interest Mar 24, 2026
From: CURIA GLOBAL, INC.
To: EOLAS THERAPEUTICS, INC.
Reel/Frame 074171/0530 →